Methylenetetrahydrofolate reductase deficiency in a patient with phenotypic findings of Angelman syndrome
- PMID: 9605586
Methylenetetrahydrofolate reductase deficiency in a patient with phenotypic findings of Angelman syndrome
Abstract
Deficiency of methylenetetrahydrofolate reductase (MTHFR) is associated with a variable phenotype that includes mental retardation, gait abnormalities, and seizures. Many of the same clinical findings are also seen in patients with Angelman syndrome. We report on a patient with MTHFR deficiency who was initially diagnosed as having Angelman syndrome. This case illustrates that MTHFR deficiency can mimic the phenotype of Angelman syndrome and that MTHFR deficiency should be excluded in patients with manifestations of Angelman syndrome whose molecular studies of chromosome 15 are normal.
Similar articles
-
Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency.Eur J Hum Genet. 1998 May-Jun;6(3):257-65. doi: 10.1038/sj.ejhg.5200182. Eur J Hum Genet. 1998. PMID: 9781030
-
Severe methylenetetrahydrofolate reductase (MTHFR) deficiency: a case report of nonclassical homocystinuria.J Child Neurol. 2008 Jul;23(7):823-8. doi: 10.1177/0883073808315410. J Child Neurol. 2008. PMID: 18658082
-
Methylenetetrahydrofolate reductase deficiency: importance of early diagnosis.J Child Neurol. 2000 Aug;15(8):539-43. doi: 10.1177/088307380001500808. J Child Neurol. 2000. PMID: 10961793
-
Angelman syndrome: mimicking conditions and phenotypes.Am J Med Genet. 2001 Jun 1;101(1):59-64. doi: 10.1002/ajmg.1316. Am J Med Genet. 2001. PMID: 11343340 Review.
-
[Methylenetetrahydrofolate reductase deficiency].Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):207-10. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9645044 Review. Japanese. No abstract available.
Cited by
-
Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.Am J Med Genet A. 2010 Aug;152A(8):1994-2001. doi: 10.1002/ajmg.a.33509. Am J Med Genet A. 2010. PMID: 20635355 Free PMC article. Clinical Trial.
-
Molecular and Clinical Aspects of Angelman Syndrome.Mol Syndromol. 2012 Apr;2(3-5):100-112. doi: 10.1159/000328837. Epub 2011 Jul 28. Mol Syndromol. 2012. PMID: 22670133 Free PMC article.
-
Update of the EMQN/ACGS best practice guidelines for molecular analysis of Prader-Willi and Angelman syndromes.Eur J Hum Genet. 2019 Sep;27(9):1326-1340. doi: 10.1038/s41431-019-0435-0. Epub 2019 Jun 24. Eur J Hum Genet. 2019. PMID: 31235867 Free PMC article.
-
Angelman syndrome: a review of the clinical and genetic aspects.J Med Genet. 2003 Feb;40(2):87-95. doi: 10.1136/jmg.40.2.87. J Med Genet. 2003. PMID: 12566516 Free PMC article. Review.
-
Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes.BMC Med Genet. 2010 May 11;11:70. doi: 10.1186/1471-2350-11-70. BMC Med Genet. 2010. PMID: 20459762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources